Stericycle Inc. (NASDAQ:SRCL) was downgraded by equities research analysts at Northcoast Research from a “buy” rating to a “neutral” rating in a research report issued on Tuesday.

Other equities analysts have also issued research reports about the company. Zacks Investment Research raised Stericycle from a “hold” rating to a “buy” rating and set a $119.00 target price on the stock in a research note on Thursday, July 21st. Jefferies Group reissued a “buy” rating and set a $140.00 target price on shares of Stericycle in a research note on Monday, July 18th. Wellington Shields lowered Stericycle from an “accumulate” rating to a “hold” rating in a research note on Friday, July 29th. Imperial Capital decreased their target price on Stericycle from $100.00 to $95.00 and set an “in-line” rating on the stock in a research note on Thursday, May 26th. Finally, Macquarie initiated coverage on Stericycle in a research note on Thursday, August 25th. They set a “neutral” rating and a $96.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have issued a buy rating to the company. Stericycle currently has an average rating of “Hold” and a consensus price target of $110.32.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Shares of Stericycle (NASDAQ:SRCL) traded down 0.46% during midday trading on Tuesday, hitting $77.64. The stock had a trading volume of 283,929 shares. The firm has a 50 day moving average price of $85.11 and a 200 day moving average price of $102.87. The stock has a market cap of $6.60 billion, a PE ratio of 27.33 and a beta of 0.27. Stericycle has a one year low of $77.00 and a one year high of $151.57.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/northcoast-research-lowers-stericycle-inc-srcl-to-neutral.html

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. During the same quarter in the prior year, the company earned $1.14 EPS. Stericycle’s revenue was up 24.6% on a year-over-year basis. On average, equities analysts forecast that Stericycle will post $4.67 earnings per share for the current fiscal year.

In related news, EVP John P. Schetz sold 1,398 shares of the firm’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the transaction, the executive vice president now owns 1,088 shares in the company, valued at approximately $89,052.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Rodney F. Dammeyer sold 10,188 shares of the firm’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the transaction, the director now owns 10,188 shares in the company, valued at approximately $871,074. The disclosure for this sale can be found here. 3.30% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Balentine LLC increased its position in Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock worth $127,000 after buying an additional 160 shares in the last quarter. Pinkerton Retirement Specialists LLC purchased a new position in Stericycle during the second quarter worth about $131,000. Parkside Financial Bank & Trust increased its position in Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in Stericycle during the second quarter worth about $155,000. Finally, Canada Pension Plan Investment Board increased its position in Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock worth $179,000 after buying an additional 497 shares in the last quarter. Hedge funds and other institutional investors own 92.81% of the company’s stock.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.